TGFB1 and atherosclerosis: TGF-β predominantly shows anti-atherogenic properties, highlighted by low serum levels being observed in patients with advanced atherosclerosis and regions of the aorta with a high probability of lesion development displaying low levels of TGF-β expression [19].